TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3184334

Group type: EXPERIMENTAL
Intervention: Low-dose oral clindamycin (150 mg/d)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 4552431

Group type: EXPERIMENTAL
Intervention: Ventolin (salbutamol)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Medihaler‐Duo (isoprenaline/phenylephrine)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Adrenaline (1/1,000) 0.5 ml
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Atropine 0.6 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no specific control mentioned)
Number of subjects: 16
Study: 30770424

Group type: EXPERIMENTAL
Intervention: Genetically instrumented vitamin D levels (increase of 10 nmol/L)
Number of subjects: 313121

Group type: EXPERIMENTAL
Intervention: APOE ε4 allele presence (specifically ε4ε4 genotype)
Number of subjects: 313121
Study: 28618158

Group type: EXPERIMENTAL
Intervention: Fitbit and Facebook mHealth intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 60
Study: 25240548

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control (uninflated cuff placed on upper arm for 40 min)
Number of subjects: 197
Study: 22554345

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (pRF)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Lidocaine injections
Number of subjects: 22
Study: 22041889

Group type: EXPERIMENTAL
Intervention: pantoprazole 20 mg once daily
Number of subjects: 800
Study: 18811792

Group type: EXPERIMENTAL
Intervention: Responsive feeding educational programme (six sessions emphasizing child self‐feeding and maternal responsiveness)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (sessions on foods to feed and nutritional disorders)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Responsive feeding educational programme
Number of subjects: 100
Study: 17234297

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring System (CGMS)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Self-monitoring of plasma glucose (SM)
Number of subjects: 73
Study: 15041584

Group type: EXPERIMENTAL
Intervention: Warm steamed towel (at 45 degrees C) for 5 min
Number of subjects: 14
Study: 11161416

Group type: EXPERIMENTAL
Intervention: Gemination at the root's end (e.g., SMM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avoidance of root-initial gemination
Number of subjects: 0
Study: 10423595

Group type: EXPERIMENTAL
Intervention: Dirithromycin (two 250 mg tablets)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (two tablets)
Number of subjects: 18
Study: 7957504

Group type: EXPERIMENTAL
Intervention: 75 g glucose load
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100 g fat load
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypertriglyceridaemic patients
Number of subjects: 10
Study: 3300449

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31335759

Group type: EXPERIMENTAL
Intervention: Pocket PATH (mobile health intervention)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Pocket PATH
Number of subjects: 105
Study: 31264958

Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 718

Group type: COMPARATOR
Intervention: Topical IOP-lowering eyedrops (Medicine-1st)
Number of subjects: 718
Study: 28408714

Group type: EXPERIMENTAL
Intervention: Low-glucose exposure group
Number of subjects: 177

Group type: COMPARATOR
Intervention: High-glucose exposure group
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: High glucose exposure
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Adjusted high glucose exposure
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 177
Study: 25740350

Group type: EXPERIMENTAL
Intervention: CPR support application
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study: 24517057

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no electric stimulation, only electrodes applied)
Number of subjects: 40
Study: 22085713

Group type: EXPERIMENTAL
Intervention: Ballet classes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 30
Study: 19843345

Group type: EXPERIMENTAL
Intervention: Custom-made leather wrist splint (LS)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Commercially available fabric splint (FS)
Number of subjects: 25
Study: 16704296

Group type: EXPERIMENTAL
Intervention: Nicotinamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15534055

Group type: EXPERIMENTAL
Intervention: High-education group (>6 years)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Low-education group (≤6 years)
Number of subjects: 58
Study: 11523315

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg o.d.)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg o.d.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 9761083

Group type: EXPERIMENTAL
Intervention: Niaspan alone (median dose 2,000 mg)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Niaspan plus a statin
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Niaspan
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Niaspan (combined with previous trials)
Number of subjects: 269
Study: 7932969

Group type: EXPERIMENTAL
Intervention: Transvaginal sonography (TVS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Endometrial biopsy
Number of subjects: 50
Study: 3048364

Group type: EXPERIMENTAL
Intervention: 5-day non-residential exercise and living course
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (10 asthmatic children)
Number of subjects: 21
Study: 31072322

Group type: EXPERIMENTAL
Intervention: Men's involvement in antenatal care services
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Joint decision making on seeking antenatal care
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Accompaniment to antenatal clinic
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Discussion with healthcare providers
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Physical support during antenatal period
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Factors influencing involvement
Number of subjects: 966
Study: 30211666

Group type: EXPERIMENTAL
Intervention: Mixed-outcome message
Number of subjects: 0

Group type: COMPARATOR
Intervention: No message
Number of subjects: 0
Study: 26879374

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate 1000 mg once daily plus prednisone 5 mg twice daily
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo plus prednisone 5 mg twice daily
Number of subjects: 214
Study: 24461175

Group type: EXPERIMENTAL
Intervention: Multi-disciplinary treatment group (n=63)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (n=54)
Number of subjects: 117
Study: 22982269

Group type: EXPERIMENTAL
Intervention: Habituation to pictures of objects in groups of two or three (intervention)
Number of subjects: 3
Study: 19473192

Group type: EXPERIMENTAL
Intervention: gluten-free diet plus 6 mg budesonide daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: gluten-free diet alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: budesonide (10-30 microg/mL) in vitro
Number of subjects: 20

Group type: COMPARATOR
Intervention: gliadin alone
Number of subjects: 20
Study: 17467265

Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 206

Group type: COMPARATOR
Intervention: Carboplatin
Number of subjects: 206
Study: 15692317

Group type: COMPARATOR
Intervention: PLAC (0.3 g.kg(‐1) body mass CaCO3 + 1 g NaCl)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.3CIT (0.3 g.kg(‐1) body mass tri-sodium citrate)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.5CIT (0.5 g.kg(‐1) body mass tri-sodium citrate)
Number of subjects: 8
Study: 12475454

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 454

Group type: COMPARATOR
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 454
Study: 9745228

Group type: EXPERIMENTAL
Intervention: Fosfomycin (FOM) followed by sulbactam/cefoperazone (SBT/CPZ)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Sulbactam/cefoperazone (SBT/CPZ) administered simultaneously with fosfomycin (FOM)
Number of subjects: 115
Study: 8539545

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil
Number of subjects: 236

Group type: COMPARATOR
Intervention: PcV
Number of subjects: 236
Study: 2116206

Group type: EXPERIMENTAL
Intervention: Intramuscular gold thiomalate
Number of subjects: 82

Group type: COMPARATOR
Intervention: Auranofin
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 678739

Group type: EXPERIMENTAL
Intervention: Videotape feedback of the interview
Number of subjects: 0

Group type: COMPARATOR
Intervention: Videotape of another person being interviewed
Number of subjects: 0

Group type: COMPARATOR
Intervention: Engaged in other activities not involving videotape
Number of subjects: 0
Study: 30998813

Group type: EXPERIMENTAL
Intervention: nab-Paclitaxel plus gemcitabine-cisplatin
Number of subjects: 62

Group type: COMPARATOR
Intervention: gemcitabine-cisplatin alone (historical control)
Number of subjects: 62
Study: 27175565

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) with active recovery (50% of peak power output)
Number of subjects: 18

Group type: COMPARATOR
Intervention: High-Intensity Interval Exercise (HIIE) with passive recovery (A and C)
Number of subjects: 18

Group type: COMPARATOR
Intervention: High-Intensity Interval Exercise (HIIE) protocol C (90 seconds with passive recovery)
Number of subjects: 18
Study: 25033263

Group type: EXPERIMENTAL
Intervention: Intermittent walking exercise (WE) - 15 × 2‐min bouts of WE with 2‐min rest intervals
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (standing rest on a treadmill for 60 min)
Number of subjects: 20
Study: 23395546

Group type: EXPERIMENTAL
Intervention: 840 mg/day DHA and 270 mg/day EPA from fish oil capsules
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo (olive oil capsules)
Number of subjects: 263
Study: 21086216

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Process-experiential emotion-focused therapy
Number of subjects: 66
Study: 19474689

Group type: EXPERIMENTAL
Intervention: Midline incision
Number of subjects: 200

Group type: COMPARATOR
Intervention: Transverse incision
Number of subjects: 200
Study: 17094744

Group type: EXPERIMENTAL
Intervention: Forced IV hydration with 2 L of normal saline over 2 hours
Number of subjects: 43

Group type: COMPARATOR
Intervention: Minimal IV hydration at 20 mL of normal saline per hour
Number of subjects: 43
Study: 15636426

Group type: EXPERIMENTAL
Intervention: DHEA 50 mg/day for 4 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo for 4 months
Number of subjects: 20
Study: 11791121

Group type: EXPERIMENTAL
Intervention: Tamoxifen, administered for 5 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ovarian ablation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-agent chemotherapy of 4-6 months duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anthracycline-containing regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taxanes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy to the regional lymph nodes and chest wall following mastectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 9164883

Group type: EXPERIMENTAL
Intervention: SCD patients
Number of subjects: 54

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 54

Group type: COMPARATOR
Intervention: Healthy subjects (night vs day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control patients (night vs day)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: SCD patients (night vs day)
Number of subjects: 54
Study: 7953984

Group type: EXPERIMENTAL
Intervention: 100 IU of intranasal salmon calcitonin (sCT)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: 200 IU of intranasal salmon calcitonin (sCT)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: 400 IU of intranasal salmon calcitonin (sCT)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: 200 IU and 400 IU of intranasal salmon calcitonin (sCT) pooled
Number of subjects: 134
Study: 3699218

Group type: EXPERIMENTAL
Intervention: Topical clobetasol propionate combined with dithranol and UVB
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dithranol and UVB alone
Number of subjects: 50
Study: 31863962

Group type: EXPERIMENTAL
Intervention: Single dose of bisphosphonate pamidronate within the first ten days of burn injury
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single dose of bisphosphonate pamidronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum from patients given single dose bisphosphonate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum from bisphosphonate treated patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibody to transforming growth factor beta (TGFβ)
Number of subjects: 0
Study: 29741773

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with weekly carboplatin (AUC 2) and paclitaxel (135 mg/m2), plus daily lapatinib (1000 mg) for 6 weeks followed by surgical resection.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with weekly carboplatin and paclitaxel, plus daily lapatinib followed by surgical resection.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy and surgical resection followed by risk-adapted adjuvant therapy.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Surgery following induction chemotherapy.
Number of subjects: 40
Study: 27568126

Group type: EXPERIMENTAL
Intervention: Mobile cognitive cardiac surgical simulator
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional reading-based self-study
Number of subjects: 16
Study: 24990099

Group type: EXPERIMENTAL
Intervention: rhAd5 injection
Number of subjects: 299

Group type: COMPARATOR
Intervention: Control group (no gene therapy)
Number of subjects: 299
Study: 22586212

Group type: EXPERIMENTAL
Intervention: Upright, sideways, or horizontal repositioning maneuvers
Number of subjects: 1

Group type: COMPARATOR
Intervention: Sleeping 1-year-olds of smokers
Number of subjects: 1
Study: 15947713

Group type: EXPERIMENTAL
Intervention: Low-salt diet (LSD)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Normal salt diet (NSD)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-salt diet (HSD)
Number of subjects: 24
Study: 12426859

Group type: EXPERIMENTAL
Intervention: Alpha1-adrenoceptor antagonists (alfuzosin, doxazosin, tamsulosin, terazosin)
Number of subjects: 14924

Group type: EXPERIMENTAL
Intervention: Alfuzosin
Number of subjects: 14924

Group type: COMPARATOR
Intervention: Alpha1-adrenoceptor antagonists
Number of subjects: 14924

Group type: COMPARATOR
Intervention: Doxazosin or terazosin
Number of subjects: 14924

Group type: EXPERIMENTAL
Intervention: Alpha1-blockers
Number of subjects: 14924
Study: 10199336

Group type: EXPERIMENTAL
Intervention: Skin sympathetic nerve activity (SSNA) reflex latency in patients with cerebellar cortical atrophy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Skin sympathetic nerve activity (SSNA) reflex latency in patients with olivopontocerebellar atrophy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Skin sympathetic nerve activity (SSNA) in patients with Shy-Drager syndrome
Number of subjects: 12

Group type: COMPARATOR
Intervention: Skin sympathetic nerve activity (SSNA) reflex latency in healthy controls
Number of subjects: 12
Study: 8537548

Group type: EXPERIMENTAL
Intervention: Low-dose recombinant human tissue plasminogen activator (rhtPA: 10 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 1691406

Group type: EXPERIMENTAL
Intervention: quinapril, 5 mg twice daily (b.i.d.)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: quinapril, 10 mg b.i.d.
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: quinapril, 20 mg b.i.d.
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: quinapril (dosage titrated to a maximum of 40 mg/day, 20 mg b.i.d.)
Number of subjects: 225

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 225
Study: 531231

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 23

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 23
Study: 31270177

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard Oxygen Therapy (standard O2)
Number of subjects: 29
Study: 29704540

Group type: EXPERIMENTAL
Intervention: Multi-component kindergarten-based intervention to promote healthy diets and reduce food neophobia.
Number of subjects: 15
Study: 28676443

Group type: EXPERIMENTAL
Intervention: Tongue Depressor (TD)
Number of subjects: 150
Study: 26181716

Group type: EXPERIMENTAL
Intervention: Telemedicine (video consultation)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Reference group (face-to-face consultation)
Number of subjects: 73
Study: 24173259

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:200,000 epinephrine
Number of subjects: 30
Study: 21195289

Group type: EXPERIMENTAL
Intervention: Real Acupuncture (RA) at HT7
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham Acupuncture (SA) at LI10
Number of subjects: 29
Study: 18410297

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg/day for the first week, then 40 mg/day for the following 3 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 16952654

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (100% O2 at 2.4 atmosphere absolute for 30 sessions)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham treatment (1.3 atmosphere absolute, breathing normal air)
Number of subjects: 21
Study: 12878284

Group type: EXPERIMENTAL
Intervention: Mirena
Number of subjects: 438

Group type: COMPARATOR
Intervention: NovaT
Number of subjects: 438
Study: 11125653

Group type: EXPERIMENTAL
Intervention: Multimedia form administered by computer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Written form administered by computer (computerized page-turner)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paper-and-pencil form
Number of subjects: 0
Study: 9177067

Group type: EXPERIMENTAL
Intervention: CPN aftercare for 1 year
Number of subjects: 127

Group type: COMPARATOR
Intervention: Standard outpatient care
Number of subjects: 127
Study: 1530169

Group type: EXPERIMENTAL
Intervention: Stripping with adhesive tape
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cleaning with benzine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Scrubbing with Skin‐Pure jelly
Number of subjects: 21
Study: 3884426

Group type: EXPERIMENTAL
Intervention: Ranitidine (0.3 g/day in 2 oral doses)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Cimetidine (1.6 g/day in 4 oral doses)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 354
Study: 30089732

Group type: EXPERIMENTAL
Intervention: Cold exposure (30-minute ice pack application each day for 10 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirabegron (β3 receptor agonist, 50 mg/day for 10 weeks)
Number of subjects: 0
Study: 27282232

Group type: EXPERIMENTAL
Intervention: Cloud-based BP system integrated with CPOE
Number of subjects: 382

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 382
Study: 24576907

Group type: EXPERIMENTAL
Intervention: 2-dose (2D) schedule of HPV-16/18 AS04-adjuvanted vaccine administered at M0,6
Number of subjects: 479

Group type: COMPARATOR
Intervention: 3-dose (3D) schedule of HPV-16/18 AS04-adjuvanted vaccine administered at M0,1,6
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: 2-dose (2D) schedule
Number of subjects: 479

Group type: COMPARATOR
Intervention: 3-dose (3D) schedule
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Both 2D and 3D schedules
Number of subjects: 479
Study: 22348812

Group type: COMPARATOR
Intervention: Air with constant flow (1.5 L/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oxygen with constant flow (1.5 L/min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Automated oxygen flow titration
Number of subjects: 10
Study: 20080288

Group type: EXPERIMENTAL
Intervention: Combination of periprostatic anesthesia and bilateral pudendal block (group 2)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Periprostatic anesthesia only (group 1)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 150
Study: 18545185

Group type: EXPERIMENTAL
Intervention: Isokinetic eccentric exercise of quadriceps femoris
Number of subjects: 24

Group type: COMPARATOR
Intervention: Resting group
Number of subjects: 24
Study: 15960148

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 12885708

Group type: EXPERIMENTAL
Intervention: NaFeEDTA-fortified fish sauce (10 g with 5 mg Fe)
Number of subjects: 50

Group type: COMPARATOR
Intervention: FeSO4-fortified fish sauce (10 g with 5 mg Fe)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NaFeEDTA-fortified soy sauce (10 g with 5 mg Fe)
Number of subjects: 50

Group type: COMPARATOR
Intervention: FeSO4-fortified soy sauce (10 g with 5 mg Fe)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NaFeEDTA-fortified fish sauce vs soy sauce
Number of subjects: 50

Group type: COMPARATOR
Intervention: Soy sauce effect on rice-based meals
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fish sauce effect on iron absorption
Number of subjects: 50
Study: 10593384

Group type: EXPERIMENTAL
Intervention: Vitrification of mouse blastocysts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitrification of human blastocysts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonfrozen blastocysts
Number of subjects: 0